Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.

B. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax) consists of aluminum-adsorbed cell-free filtrates...

Full description

Bibliographic Details
Main Authors: Ravi V Kolla, Suresh Chintalapati, Mojgan Sabet, Eugenio Santelli, Robert C Liddington, Michael David, Joshua Fierer, Donald Guiney, Robert C Rickert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-10-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2001179?pdf=render
_version_ 1828870018403663872
author Ravi V Kolla
Suresh Chintalapati
Mojgan Sabet
Eugenio Santelli
Robert C Liddington
Michael David
Joshua Fierer
Donald Guiney
Robert C Rickert
author_facet Ravi V Kolla
Suresh Chintalapati
Mojgan Sabet
Eugenio Santelli
Robert C Liddington
Michael David
Joshua Fierer
Donald Guiney
Robert C Rickert
author_sort Ravi V Kolla
collection DOAJ
description B. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax) consists of aluminum-adsorbed cell-free filtrates of unencapsulated B. anthracis, wherein PA is thought to be the principle target of neutralization. In this study, we evaluated the efficacy of the natural adjuvant, C3d, versus alum in eliciting an anti-PA humoral response and found that C3d conjugation to PA and emulsion in incomplete Freund's adjuvant (IFA) imparted superior protection from anthrax challenge relative to PA in IFA or PA adsorbed to alum. Relative to alum-PA, immunization of mice with C3d-PA/IFA augmented both the onset and sustained production of PA-specific antibodies, including neutralizing antibodies to the receptor-binding portion (domain 4) of PA. C3d-PA/IFA was efficacious when administered either i.p. or s.c., and in adolescent mice lacking a fully mature B cell compartment. Induction of PA-specific antibodies by C3d-PA/IFA correlated with increased efficiency of germinal center formation and plasma cell generation. Importantly, C3d-PA immunization effectively protected mice from intranasal challenge with B. anthracis spores, and was approximately 10-fold more effective than alum-PA immunization or PA/IFA based on dose challenge. These data suggest that incorporation of C3d as an adjuvant may overcome shortcomings of the currently licensed aluminum-based vaccine, and may confer protection in the early days following acute anthrax exposure.
first_indexed 2024-12-13T06:02:40Z
format Article
id doaj.art-cc048ca0d52943f0ab8072f3caa8eeb1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T06:02:40Z
publishDate 2007-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cc048ca0d52943f0ab8072f3caa8eeb12022-12-21T23:57:18ZengPublic Library of Science (PLoS)PLoS ONE1932-62032007-10-01210e104410.1371/journal.pone.0001044Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.Ravi V KollaSuresh ChintalapatiMojgan SabetEugenio SantelliRobert C LiddingtonMichael DavidJoshua FiererDonald GuineyRobert C RickertB. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax) consists of aluminum-adsorbed cell-free filtrates of unencapsulated B. anthracis, wherein PA is thought to be the principle target of neutralization. In this study, we evaluated the efficacy of the natural adjuvant, C3d, versus alum in eliciting an anti-PA humoral response and found that C3d conjugation to PA and emulsion in incomplete Freund's adjuvant (IFA) imparted superior protection from anthrax challenge relative to PA in IFA or PA adsorbed to alum. Relative to alum-PA, immunization of mice with C3d-PA/IFA augmented both the onset and sustained production of PA-specific antibodies, including neutralizing antibodies to the receptor-binding portion (domain 4) of PA. C3d-PA/IFA was efficacious when administered either i.p. or s.c., and in adolescent mice lacking a fully mature B cell compartment. Induction of PA-specific antibodies by C3d-PA/IFA correlated with increased efficiency of germinal center formation and plasma cell generation. Importantly, C3d-PA immunization effectively protected mice from intranasal challenge with B. anthracis spores, and was approximately 10-fold more effective than alum-PA immunization or PA/IFA based on dose challenge. These data suggest that incorporation of C3d as an adjuvant may overcome shortcomings of the currently licensed aluminum-based vaccine, and may confer protection in the early days following acute anthrax exposure.http://europepmc.org/articles/PMC2001179?pdf=render
spellingShingle Ravi V Kolla
Suresh Chintalapati
Mojgan Sabet
Eugenio Santelli
Robert C Liddington
Michael David
Joshua Fierer
Donald Guiney
Robert C Rickert
Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
PLoS ONE
title Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
title_full Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
title_fullStr Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
title_full_unstemmed Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
title_short Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response.
title_sort complement c3d conjugation to anthrax protective antigen promotes a rapid sustained and protective antibody response
url http://europepmc.org/articles/PMC2001179?pdf=render
work_keys_str_mv AT ravivkolla complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT sureshchintalapati complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT mojgansabet complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT eugeniosantelli complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT robertcliddington complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT michaeldavid complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT joshuafierer complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT donaldguiney complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse
AT robertcrickert complementc3dconjugationtoanthraxprotectiveantigenpromotesarapidsustainedandprotectiveantibodyresponse